The supplement of iodometicolin (IMC) or fluoromethylcholine (FMC), selective inhibitors for the bacterial genes involved in the production of TMAO, allows to reduce the plasma levels going therefore to decrease the risk of thrombosis but without the systemic effects often associated with the use of antiplatelet drugs.

read more…..